Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-30

FDA Approved: MUPIROCIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark Pharmaceuticals Inc., USA's supplemental application for mupirocin (generic topical ointment) under ANDA 201587. This action updates/expan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mupirocin (Mupirocin)

Snippet

SUPPL AP for MUPIROCIN (MUPIROCIN)